+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A phase II trial of recombinant human granulocyte macrophage-colony stimulating factor recombinant human interleukin-4 used as combination therapy for subjects with hormone refractory prostate cancer



A phase II trial of recombinant human granulocyte macrophage-colony stimulating factor recombinant human interleukin-4 used as combination therapy for subjects with hormone refractory prostate cancer



Journal of Investigative Medicine 50(2): 166A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034314250

Download citation: RISBibTeXText


Related references

Effect of recombinant human growth factors: recombinant human interleukin-6, recombinant human granulocyte-macrophage colony-stimulating-factor and recombinant human erythropoietin on normal human hematopoietic progenitor cells. Zhonghua Nei Ke Za Zhi 33(5): 298-301, 1994

Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor. Journal of Clinical Oncology 10(8): 1352-1358, 1992

Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997. Leukemia Research 30(7): 823-827, 2006

A phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia receiving high-dose cytarabine during induction ECOG 3997. Blood 96(11 Part 1): 323a, 2000

The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project. American Journal of Clinical Oncology 17(5): 374-81; Discussion 382, 1994

Recombinant human interleukin 3 and recombinant human granulocyte macrophage colony stimulating factor administered in vivo after high dose cyclophosphamide cancer chemotherapy effect on hematopoiesis and microenvironment in human bone marrow. Blood 79(10): 2610-2619, 1992

Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3: comparison with human recombinant granulocyte and granulocyte-macrophage colony-stimulating factor. Proceedings of the National Academy of Sciences of the United States of America 84(19): 6765-6769, 1987

Growth of human hemopoietic colonies in response to recombinant gibbon interleukin 3 il3 in comparison with human recombinant granulocyte g csf and granulocyte macrophage colony stimulating factor gm csf. Experimental Hematology 15(5): 563, 1987

The Efficacy of Recombinant Human Granulocyte Colony-Stimulating Factor and Recombinant Human Granulocyte Macrophage Colony-Stimulating Factor in Permitting the Administration of Higher Doses of Cyclophosphamide in a Doxorubicin-Cyclophosphamide Combination. American Journal of Clinical Oncology 17(5): 374-381, 1994

Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice. Journal of Cellular Biochemistry 38(2): 127-136, 1988

Response of CFU-GM (colony forming units for granulocytes and macrophages) from intact and pinealectomized rat bone marrow to murine recombinant interleukin-3 (rIl-3), recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF) and human recombinant erythropoietin (rEPO). Progress in Brain Research 91: 323-325, 1992

Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells. Journal of Immunology 159(2): 838-845, 1997

Combined administration of recombinant human granulocyte macrophage colony stimulating factor and recombinant human erythropoietin in a patient with refractory anemia. Miyazaki, T , F Takaku And H Uchino (Ed ) International Congress Series, 956 Myelodysplastic Syndrome And Cytokines; International Symposium, Sapporo, Japan, September 28-29, 1990 Xii+325p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York) Illus 187-190, 1991

Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha tumor necrosis factor alpha granulocyte colony stimulating factor and murine recombinant granulocyte macrophage colony stimulating factor. Journal of Immunology 140(1): 108-111, 1988

Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor. Blood 93(8): 2653-2659, 1999